Core Viewpoint - The article discusses the impact of the upcoming export tax rebate cancellation on various companies in the glyphosate industry, highlighting their strategies to mitigate cost pressures and capitalize on market opportunities. Group 1: Company Strategies and Advantages - Xingfa Group, a leading player in the phosphate chemical industry, benefits from a complete supply chain and cost control, allowing it to quickly pass on cost pressures post-export tax rebate cancellation [1][19] - Yangnong Chemical, a leader in the biorational pesticide sector, plans to shift towards high-value formulation exports, leveraging its strong overseas registration and channel networks [2][20] - Hebang Biotechnology has a high self-sufficiency rate in raw materials, which helps it mitigate cost increases and capture orders during overseas inventory replenishment cycles [3][19] - Runfeng Co., a prominent pesticide exporter, can quickly adjust its product structure to high-value formulations, benefiting from its global partnerships and supply chain flexibility [4][20] - Xin'an Chemical, known for its integrated production model, significantly reduces costs and enhances flexibility in price transmission through its dual production of organic silicon and glyphosate [5][21] Group 2: Market Position and Growth Potential - Taihe Co. focuses on raw material production and aims to expand its market share by optimizing production costs and enhancing its domestic formulation market presence [6][22] - Andermatt Biocontrol, a global leader in pesticide formulations, plans to leverage its strong R&D capabilities and global network to maintain market leadership post-tax rebate changes [7][24] - Lier Chemical, with a complete R&D and production system, aims to enhance its market position through technological upgrades and a stable raw material supply chain [8][25] - Nopson, a leading pesticide formulation company, is expected to strengthen its domestic market position by quickly adapting to changes in export pressures [9][26] - Jiangshan Co., a top glyphosate producer, is positioned to benefit from its scale and technological advantages, allowing it to consolidate market share amid industry restructuring [10][28] Group 3: Industry Trends and Challenges - The glyphosate industry is experiencing consolidation, with companies poised to capture market share from smaller players exiting the market due to increased competition and regulatory pressures [11][29] - Companies are focusing on technological advancements and product iterations to address challenges such as glyphosate resistance and to enhance their competitive edge [12][30] - The shift towards high-value formulations and domestic market focus is a common strategy among companies to mitigate the impact of the export tax rebate cancellation [13][34]

Group 1 - The glyphosate concept sector rose by 3.46%, ranking third among concept sectors, with 16 stocks increasing in value, including Lier Chemical which hit the daily limit, and Jiangshan Co., Yangnong Chemical, and Hongtaiyang with increases of 7.62%, 5.36%, and 4.12% respectively [1][2] - The glyphosate concept sector saw a net inflow of 274 million yuan from main funds, with 10 stocks receiving net inflows, and 5 stocks exceeding 10 million yuan in net inflow, led by Lier Chemical with a net inflow of 103 million yuan [2][3] - The top net inflow ratios for main funds were Lier Chemical at 16.27%, Hongtaiyang at 16.12%, and Nuofushin at 14.41% [3][4] Group 2 - The trading performance of Lier Chemical showed a daily increase of 10.01% with a turnover rate of 5.01%, while Jiangshan Co. had a notable increase of 7.62% with a turnover rate of 4.74% [3][4] - Other companies in the glyphosate sector, such as Xingfa Group and Nuofushin, also reported positive daily increases of 2.70% and 3.72% respectively, indicating a strong interest from investors [3][4] - The overall market sentiment towards the glyphosate sector appears positive, as evidenced by the significant net inflows and the performance of key stocks within the sector [2][3]

Core Viewpoint - Xingfa Group's stock has shown significant growth, with a year-to-date increase of 19.20% and a 54.79% rise over the past 60 days, indicating strong market performance and investor interest [1]. Group 1: Stock Performance - As of January 19, Xingfa Group's stock price reached 41.22 CNY per share, with a trading volume of 5.00 billion CNY and a market capitalization of 454.76 billion CNY [1]. - The stock has experienced a 13.37% increase over the last 5 trading days and a 25.75% increase over the last 20 trading days [1]. Group 2: Financial Performance - For the period from January to September 2025, Xingfa Group reported a revenue of 237.81 billion CNY, reflecting a year-on-year growth of 7.85%, while the net profit attributable to shareholders was 13.18 billion CNY, with a slight increase of 0.31% [2]. Group 3: Shareholder Information - As of January 9, 2025, the number of shareholders for Xingfa Group was 45,400, a decrease of 0.89% from the previous period, with an average of 24,301 circulating shares per shareholder, which increased by 0.90% [2]. - The company has distributed a total of 48.14 billion CNY in dividends since its A-share listing, with 28.69 billion CNY distributed over the past three years [3]. Group 4: Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the eighth largest circulating shareholder, holding 12.038 million shares, an increase of 1.8178 million shares from the previous period [3]. - Penghua CSI Sub-Industry Chemical Theme ETF Connect A and Southern CSI 500 ETF were also among the top ten circulating shareholders, with the former being a new shareholder [3].

Core Insights - The expiration of the compound patent for Pyraclostrobin in China has led to a surge in domestic interest, with companies increasing registration, production, and promotion efforts [1][6] - As of 2024, there are 62 registered Pyraclostrobin products in China, including 32 active ingredients and 30 formulations, primarily targeting wheat and peanut crops [1][6] - The global market for Pyraclostrobin has seen significant growth, with sales expected to rise from $973 million in 2015 to $2.014 billion by 2024, and projected to reach $2.172 billion by 2025 [5][11] Industry Overview - Pyraclostrobin, developed by Bayer in 2004, is a broad-spectrum fungicide known for its low toxicity and effectiveness against various plant diseases [2][3] - It is particularly effective against diseases affecting cereals and legumes, making it a key product in the global fungicide market, holding an 8% market share [3][5] Market Dynamics - The Chinese market for Pyraclostrobin is expanding rapidly due to the high incidence of wheat diseases, particularly Fusarium head blight, which can cause yield losses of 10% to 20% in epidemic years [7][11] - The area affected by Fusarium head blight in China is projected to reach 15 million acres in 2024, an increase of 6 million acres from 2023 [7][8] Competitive Landscape - Major companies in the Pyraclostrobin sector include Hailir, Anhui Jiuyi, Nantong Taihe, and Guangdong Guokang, among others, with many expanding production capacity [9][10] - Hailir reported a revenue of 3.391 billion yuan in the first nine months of 2025, a 5.5% increase year-on-year, indicating strong market performance [10] Future Trends - The demand for Pyraclostrobin is expected to continue rising due to increasing occurrences of wheat diseases and advancements in application methods [11] - The market is becoming increasingly competitive, with potential oversupply leading to price fluctuations, necessitating companies to optimize production and enhance brand presence [12] - The trend towards formulation mixtures is anticipated to grow, as combining Pyraclostrobin with other chemicals can delay resistance development and enhance efficacy [13]

Investment Rating - The industry investment rating is "Positive" (maintained) [2] Core Viewpoints - The report highlights the impact of the recent cancellation and reduction of export tax rebates on pesticides, particularly focusing on the potential for price increases and improved profitability for leading companies in the pesticide sector [5] - The report anticipates a reversal in the pesticide industry's performance due to rising export costs and the upcoming spring farming season, which is expected to boost demand and prices [5] - The ongoing "anti-involution" trend in the pesticide industry is expected to optimize supply and reshape value, encouraging companies to shift from low-end manufacturing to a focus on technology, branding, and service [5] Summary by Relevant Sections Industry Overview - The pesticide industry is experiencing a significant shift due to policy changes, with the cancellation of export tax rebates for various pesticide raw materials and intermediates, including glyphosate and other high-toxicity products [4][5] - China is projected to export 2.05 million tons of pesticides in 2024, with exports accounting for 90% of production [5] Market Dynamics - The domestic pesticide production peak season occurs from February to May, with a significant increase in demand for pesticide formulations during this period [5] - The report notes that the price of 95% glyphosate raw powder has recently increased to 46,000 yuan per ton, indicating a recovery in pricing [11] Key Companies and Recommendations - Recommended stocks include leading pesticide companies such as Yangnong Chemical, Limin Co., and Xingfa Group, which are expected to benefit from the price increases and the integrated "raw material-formulation" model [5] - Beneficiary stocks also include Jiangshan Chemical, Lier Chemical, and others involved in various segments of the pesticide supply chain [5]

Group 1 - On January 16, Xingfa Group executed a block trade of 200,000 shares, with a transaction amount of 8.082 million yuan, accounting for 1.22% of the total trading volume for the day [1][2] - The transaction price was 40.41 yuan, which was consistent with the market closing price of 40.41 yuan [1][2]

Group 1 - The core point of the article highlights the recent performance of Xingfa Group, which saw a stock price increase of 2.28% to close at 40.45 yuan, with a significant block trade executed [1] - A total of 100,000 shares were traded in the block transaction, amounting to 4.045 million yuan, with a premium rate of 0.00% [1] - The buyer of the block trade was CITIC Securities Co., Ltd., while the seller was China International Capital Corporation [1] Group 2 - In the last three months, there has been only one block trade for the stock, totaling 4.045 million yuan [1] - Over the past five trading days, the stock has increased by 8.01%, with a net inflow of 25.2204 million yuan from major funds [1]

Core Viewpoint - The chemical ETF Tianhong (159133) has seen significant inflows and performance, reflecting a positive outlook for the chemical industry as it undergoes structural changes and optimization [2][3]. Group 1: ETF Performance - As of January 14, the chemical ETF Tianhong (159133) reached a new high with a total size of 843 million yuan and 735 million shares outstanding [2]. - The ETF has experienced continuous net inflows over the past 11 days, accumulating a total of 233 million yuan [2]. Group 2: Industry Trends - The Ministry of Finance announced the cancellation of the 13% export tax rebate on PVC powder starting April 1, 2026, which is expected to increase export costs by approximately 75 USD per ton. This may lead to a short-term surge in exports and a long-term shift towards high-value products and overseas capacity [2]. - The chemical industry is currently at a historical low point, with a shift from capacity expansion to optimization driven by "anti-involution" policies. Key sectors such as coal chemical, organic silicon, and pesticides are expected to see a supply-demand reversal [3]. Group 3: Investment Opportunities - Leading companies in the chemical sector are anticipated to benefit from the ongoing exit of low-efficiency capacity and the transition to high-value products, with potential profit recovery expected [3]. - Sub-industries with resource attributes or technical barriers, such as phosphorus chemicals and refrigerants, may present opportunities for value reassessment [3].

Core Viewpoint - Xingfa Group announced the approval of several proposals related to expected daily related transactions for the year 2026 during its first extraordinary shareholders' meeting [1] Group 1 - The company approved the proposal regarding expected daily related transactions with Yichang Xingfa Group Co., Ltd. and its subsidiaries for the year 2026 [1] - The company also approved the proposal concerning expected daily related transactions with Zhejiang Jinfanda and its related parties, as well as the Three Gorges Laboratory for the year 2026 [1] - Additionally, the company passed a proposal related to the establishment of certain measures [1]

| 证券代码：600141 | 证券简称：兴发集团 | 公告编号：临 2026-002 | | --- | --- | --- | | 转债代码：110089 | 转债简称：兴发转债 | | 湖北兴发化工集团股份有限公司 2026年度第一次临时股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 665 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 463,001,904 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 41.9667 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，会议主持情况等。 (一) 股东会召开的时间：2026 年 1 月 14 日 (二) 股东会召开的地点：湖北省宜昌市伍家岗区沿江大道 188-9 号兴发大厦 3307 室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持 ...